July 20-24, 2026, Balt teams attended the SNIS Annual Meeting in Seattle, the first major conference following the approval of Squid in the United States. SNIS provided an ideal platform to showcase Balt’s innovation, strengthen engagement with healthcare professionals, and highlight the company’s continued momentum in the U.S. market.